Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Finance
Payers
Evernorth's Accredo to offer Humira biosim at $0 out-of-pocket
Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced on Thursday.
Paige Minemyer
Apr 25, 2024 4:30pm
Acute, behavioral revenue gains push UHS to $262M Q1 profit
Apr 24, 2024 11:39pm
CHS logs expected Q1 net loss but beats on revenues
Apr 24, 2024 10:38pm
UPMC laying off roughly 1,000 workers
Apr 24, 2024 3:00pm
Summer Health pockets $12M for text-based pediatric service
Apr 24, 2024 8:00am
Humana pulls back 2025 guidance following MA rate cut
Apr 24, 2024 7:23am